On 2025-05-13, Passage Bio, Inc. (PASG) announced earnings per share of $-0.25 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.24.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.20 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.24 | $-0.25 |
| 2025-03-04 | 2024-12-31 | $-0.21 | $-0.20 |
| 2024-11-13 | 2024-09-30 | $-0.23 | $-0.31 |
| 2024-08-08 | 2024-06-30 | $-0.31 | $-0.26 |
| 2024-05-14 | 2024-03-31 | $-0.37 | $-0.30 |
| 2024-03-04 | 2023-12-31 | $-0.41 | $-0.30 |
| 2023-11-13 | 2023-09-30 | $-0.47 | $-0.49 |
| 2023-08-07 | 2023-06-30 | $-0.48 | $-0.44 |
| 2023-05-11 | 2023-03-31 | $-0.49 | $-0.63 |
| 2023-03-06 | 2022-12-31 | $-0.48 | $-0.50 |
| 2022-11-10 | 2022-09-30 | $-0.75 | $-0.49 |
| 2022-08-04 | 2022-06-30 | $-0.78 | $-0.73 |
| 2022-05-16 | 2022-03-31 | $-0.88 | $-0.79 |
| 2022-03-03 | 2021-12-31 | $-0.84 | $-0.93 |
| 2021-11-04 | 2021-09-30 | $-0.80 | $-0.77 |
| 2021-08-05 | 2021-06-30 | $-0.73 | $-0.90 |
| 2021-05-05 | 2021-03-31 | $-0.66 | $-0.76 |
| 2021-03-03 | 2020-12-31 | $-0.69 | $-0.85 |
| 2020-11-10 | 2020-09-30 | $-0.73 | $-0.63 |
| 2020-08-13 | 2020-06-30 | $-0.60 | $-0.60 |
| 2020-05-11 | 2020-03-31 | $-0.46 | $-1.00 |